IN8BIO, Inc.
INAB· Nasdaq
INABIN8BIO, Inc.
Filed Aug 6, 2026 · 10-Q · 37 days after period end · 0001193125-26-338012
| Metric | Q2 2026 | Q2 2025 | Q2 2024 | Q2 2023 |
|---|---|---|---|---|
| Net Income | -$4.78M | -$5.09M | -$8.63M | -$7.72M |
| EPS Diluted | -$0.25 | -$1.24 | -$5.51 | -$0.27 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
IN8BIO, Inc. · CIK 1740279 · Engraved from SEC EDGAR
ended Jun 30, 2026 · filed Aug 6, 2026 · 37 d after period end
